- Home
- SRG vs DERM Comparison
SRG vs DERM Comparison
Compare SRG & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRG
- DERM
- Stock Information
- Founded
- SRG 2014
- DERM 2014
- Country
- SRG United States
- DERM United States
- Employees
- SRG N/A
- DERM N/A
- Industry
- SRG Real Estate Investment Trusts
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- SRG Real Estate
- DERM Health Care
- Exchange
- SRG Nasdaq
- DERM Nasdaq
- Market Cap
- SRG 206.7M
- DERM 165.6M
- IPO Year
- SRG 2015
- DERM 2021
- Fundamental
- Price
- SRG $3.81
- DERM $7.04
- Analyst Decision
- SRG
- DERM Strong Buy
- Analyst Count
- SRG 0
- DERM 3
- Target Price
- SRG N/A
- DERM $12.67
- AVG Volume (30 Days)
- SRG 129.3K
- DERM 218.8K
- Earning Date
- SRG 08-14-2025
- DERM 08-12-2025
- Dividend Yield
- SRG N/A
- DERM N/A
- EPS Growth
- SRG N/A
- DERM N/A
- EPS
- SRG N/A
- DERM N/A
- Revenue
- SRG $15,346,000.00
- DERM $56,397,000.00
- Revenue This Year
- SRG N/A
- DERM $28.10
- Revenue Next Year
- SRG N/A
- DERM $53.84
- P/E Ratio
- SRG N/A
- DERM N/A
- Revenue Growth
- SRG N/A
- DERM N/A
- 52 Week Low
- SRG $2.43
- DERM $3.54
- 52 Week High
- SRG $4.77
- DERM $8.90
- Technical
- Relative Strength Index (RSI)
- SRG 69.40
- DERM 44.17
- Support Level
- SRG $3.61
- DERM $6.88
- Resistance Level
- SRG $3.74
- DERM $7.12
- Average True Range (ATR)
- SRG 0.13
- DERM 0.27
- MACD
- SRG 0.02
- DERM -0.04
- Stochastic Oscillator
- SRG 87.34
- DERM 16.90
About SRG Seritage Growth Properties
Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.